Upgrade programs for our latest technology

Get access to our newest diabetes technologies at an affordable price.

In-warranty customers

If you have a MiniMed insulin pump with more than 6 months remaining in your warranty, you can upgrade to our latest technology for only $499.1

See terms

Don’t have an in-warranty MiniMed pump?
We have options for you too!

 

 

Customers with in-warranty GuardianTM transmitters

If you are currently using an in-warranty transmitter compatible with our MiniMedTM 630G, MiniMedTM 670G, or GuardianTM Connect systems, you may be eligible to receive a new GuardianTM 4 transmitter at no cost when you upgrade to the MiniMedTM 780G system.3

 

See terms

Not yet a MiniMed customer?

If you are using an in-warranty pump from another company, you may upgrade to our latest technology for up to $499.2

Learn more

Discover the MiniMed FlexTM system

|

Get started

 

PROGRAMS TERMS AND CONDITIONS:

1. General Pump Pathway Program

  • Customers with and in warranty insulin pump with more than six months remaining on their warranty (or 5-year Medicare guideline) are eligible for the Pathway Program.
  • The Pump Pathway Program is for hardware pump upgrades only.
  • A $499 payment will be required upfront to utilize the Pump Pathway Program. The program price includes one (1) insulin pump. CGM products and consumables are not included.
  • The Traditional Pathway Program does not extend the warranty period of the replaced product.
  • MiniMedTM pumps have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your healthcare provider regarding indications for use.
  • Customers should verify that their insurance provider will support transitioning to the new pump, as it could affect ongoing coverage of their future pump supplies.
  • Customers must return their old pump within 30 days. Customers who do not return their pump will be charged $4,500.
  • Medicare customers within the 13-month rental period on a MiniMed™ pump cannot participate in this program.
  • Customer agrees to fully and accurately report in submissions to federal healthcare programs all discounts provided by Medtronic and, upon request by the Secretary of the U.S. Department of Health and Human Services or state agency, make available any information that Medtronic may provide concerning the discount.
  • A valid prescription will be required to purchase a new pump. Other restrictions may apply.
  • Pricing, terms, and conditions are subject to change at any time and without notice.

2. Switch2System Program

  • Customers with more than six months remaining on their competitive pump warranty (or 5-year Medicare guideline) are eligible for the Switch2System Program.
  • A $499 payment will be required to use this program. This price includes one (1) insulin pump, one (1) compatible transmitter, one (1) month of consumables and one (1) month of sensors.
  • Customers enrolled in federal, state, or government-funded healthcare plans are excluded from receiving a transmitter and sensors from this program and cannot participate in a payment plan.
  • An ABN will be required to utilize this program for all Medicare customers.
  • Customers may return product that has been shipped as part of this program up to 90 days from the date of shipment.
  • Customers must return their competitor pump or receiver within 90 days. Customers who do not return their pump will be charged $4,500.
  • This program does not extend the warranty period of the replaced pump. The customer’s current pump warranty timeline will not change by purchasing a pump through this program.
  • Customers should verify that their insurance provider will support transitioning to the new pump, as it could affect ongoing coverage of their future pump supplies.
  • Customer agrees to fully and accurately report in submissions to federal healthcare programs all discounts provided by Medtronic and, upon request by the Secretary of the U.S. Department of Health and Human Services or state agency, make available information any information that Medtronic may provide concerning the discount.
  • MiniMed™ pumps have certain labeling restrictions that may exclude certain populations, including age and type of diabetes. We recommend you consult your Healthcare Provider regarding indications for use.
  • A valid prescription will be required to purchase a pump, CGM and supplies. Other restrictions may apply.
  • Medicare customers within a 13-month rental period cannot participate in this program.
  • Customers using Kaiser health plans are excluded from this program.
  • Pricing, terms, and conditions are subject to change at any time and without notice.

3. Continuous Glucose Monitor (CGM) Supply Allowance Process

  • The Continuous Glucose Monitor (CGM) Supply Allowance Process is for CGM upgrades only. CGM supplies are included as prescribed.
  • Customers transitioning from one CGM system will not have any upfront out-of-pocket transmitter cost for the opportunity to transition to another CGM transmitter.
  • Applicable out-of-pocket CGM supply costs will apply.
  • Upon completion of the transaction, customers will receive one (1) transmitter that is compatible with their current pump system along with their monthly one (1) 5-pack of compatible sensors and other CGM supplies as prescribed.
  • This process is available to customers whose payers utilize a monthly CGM supply allowance. Customers with insurance providers that bill transmitters and sensors separately are excluded from this process.

Important Safety Information: MiniMed FlexTM system with SmartGuardTM technology with Simplera SyncTM sensor and Instinct sensor

The MiniMed FlexTM system is intended for the continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable rates for the management of type 1 diabetes mellitus in persons 7 years of age and older, and of type 2 diabetes mellitus in persons 18 years of age and older requiring insulin. The system is also intended to continuously monitor glucose values in the fluid under the skin. 

The MiniMed FlexTM system includes SmartGuardTM technology, which can be programmed to automatically adjust insulin delivery based on continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values. The system is intended for use with connected sensors, including the Simplera SyncTM sensor and integrated continuous glucose monitors, including the Instinct sensor, each of which has different wear-time, form factor, insertion site, and other distinguishing characteristics that relate to sensor performance. Consult the appropriate sensor user guide when using the system.  Discuss treatment decisions with your HCP. 

WARNING: Do not use the SmartGuardTM feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuardTM feature.  

WARNING: Do not use the MiniMedTM Flex system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMedTM Flex system. 

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuardTM feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a blood glucose (BG) meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia. 

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed FlexTM system has not been studied in pregnant women or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including user guides and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, see https://bit.ly/MiniMedRisks.

 

©2026 Medtronic MiniMed, Inc. MiniMed and MiniMed logo are trademarks of Medtronic MiniMed, Inc. The sensor shape and appearance, Abbott, and “a” logo are marks and/or designs of the Abbott group of companies in various territories and used under license. Sensor image ©2026 Abbott. TM*Third–party brands are trademarks of their respective owners.